This document provides a segmentation, targeting, positioning, and marketing strategy for Metabical, a new prescription weight loss drug. It segments the market into doctors, patients, and insurance companies. The target audience is males and females aged 50+ with a BMI of 25-30. The positioning positions Metabical as providing a credible way to lose weight and live healthily. The marketing strategy includes medical journal articles, conferences, an online support program, competitions, and endorsements. It allocates most of the $20 million budget to convincing doctors followed by promotional activities and advertising.